Eledon Pharmaceuticals, Inc. (ELDN) vs Keros Therapeutics, Inc. (KROS)
Eledon Pharmaceuticals, Inc. and Keros Therapeutics, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Keros Therapeutics, Inc. are of similar size ($229.0M and $228.3M). Across the 10 metrics below, Keros Therapeutics, Inc. leads on 9 and Eledon Pharmaceuticals, Inc. on 1.
Valuation
Profitability
| Metric | ELDN | KROS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (236.51%) | (17.16%) | (57.72%) |
| Return on assets | (72.74%) | (15.92%) | (49.22%) |
| Return on invested capital | 0.00% | (1,345.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack